Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

PURPOSE: Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy. Genomic classifiers offer the potential to more accurately identify individuals who benefit from chemotherapy than clinicopathologic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Goldstein, Lori J., Gray, Robert, Badve, Sunil, Childs, Barrett H., Yoshizawa, Carl, Rowley, Steve, Shak, Steven, Baehner, Frederick L., Ravdin, Peter M., Davidson, Nancy E., Sledge, George W., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Sparano, Joseph A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2008
Materias:
Breast Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654377/
https://ncbi.nlm.nih.gov/pubmed/18678838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.4501
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares